Proposed Data Collections Submitted for Public Comment and Recommendations, 66363-66364 [2013-26469]

Download as PDF Federal Register / Vol. 78, No. 214 / Tuesday, November 5, 2013 / Notices LeRoy Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2013–26436 Filed 11–4–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60-Day-14–0210] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–7570 or send comments to CDC, LeRoy Richardson, 1600 Clifton Road, MS D–74, Atlanta, GA 30333 or send an email to omb@ cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project List of Ingredients Added to Tobacco in the Manufacture of Cigarette Products (OMB No. 0920–0210, exp. 2/28/2014)— Extension—Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description Cigarette smoking is the leading preventable cause of premature death and disability in the United States. Each year, more than 443,000 premature deaths occur as the result of diseases related to cigarette smoking. The Centers for Disease Control and Prevention (CDC), Office on Smoking and Health (OSH) has the primary responsibility for the Department of Health and Human Services (HHS) smoking and health program. HHS’s overall goal is to reduce death and disability resulting from cigarette smoking and other forms of tobacco use through programs of information, education and research. The Comprehensive Smoking Education Act of 1984 (CSEA, 15 U.S.C. 1336 or Pub. L. 98–474) requires each person who manufactures, packages, or imports cigarettes to provide the Secretary of HHS with a list of ingredients added to tobacco in the manufacture of cigarettes. The legislation also authorizes HHS to undertake research, and to report to the Congress (as deemed appropriate) discussing the health effects of these ingredients. HHS has delegated responsibility for implementing the CSEA’s ingredient reporting requirements to CDC’s OSH. OSH has collected ingredient reports on cigarette products since 1986. 66363 Respondents are commercial cigarette manufacturers, packagers, or importers, or their designated representatives. Respondents are not required to submit specific forms; however, they are required to submit a list of all ingredients used in their products. CDC requires the ingredient report to be submitted by chemical name and Chemical Abstract Service (CAS) Registration Number, consistent with accepted reporting practices for other companies currently required to report ingredients added to other consumer products. Typically, respondents submit a summary report to CDC with the ingredient information for multiple products, or a statement that there are no changes to their previously submitted ingredient report. The estimated burden per response is 6.5 hours. The total estimated annualized burden hours are 501. Ingredient reports for new products are due at the time of first importation. Thereafter, ingredient reports are due annually on March 31. Information is submitted to OSH by mailing a written report on the respondent’s letterhead, which may be accompanied by a compact disk (CD), three-inch floppy disk, or thumb drive. Annual ingredient reports should be mailed to: Office on Smoking and Health, Attention: FCLAA Program Manager, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, NE., MS F–79 Atlanta, GA 30341–3717. Electronic mail submissions are not accepted. Upon receipt and verification of the annual ingredient report, OSH issues a Certificate of Compliance to the respondent. There are no costs to respondents other than their time. Office of Management and Budget (OMB) approval is requested for three years. Estimated Annualized Burden Hours Number of respondents Number of responses per respondent Average burden per response (in hours) Total burden (in hours) Cigarette Manufacturers, Packagers, and Importers ....................................... wreier-aviles on DSK5TPTVN1PROD with NOTICES Type of respondents 77 1 6.5 501 VerDate Mar<15>2010 15:22 Nov 04, 2013 Jkt 232001 PO 00000 Frm 00035 Fmt 4703 Sfmt 9990 E:\FR\FM\05NON1.SGM 05NON1 66364 Federal Register / Vol. 78, No. 214 / Tuesday, November 5, 2013 / Notices Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2013–26469 Filed 11–4–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–3110–FN] Medicare & Medicaid Programs: Application From the Accreditation Commission for Health Care for Continued CMS-Approval of Its Hospice Accreditation Program Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Final notice. AGENCY: This final notice announces our decision to approve the Accreditation Commission for Health Care (ACHC) for continued recognition as a national accrediting organization for hospices that wish to participate in the Medicare or Medicaid programs. DATES: Effective: This final notice is effective November 27, 2013 through November 27, 2019. FOR FURTHER INFORMATION CONTACT: Valarie Lazerowich, (410) 786–4750. Cindy Melanson, (410) 786–0310. Patricia Chmielewski, (410) 786–6899. SUPPLEMENTARY INFORMATION: wreier-aviles on DSK5TPTVN1PROD with NOTICES SUMMARY: I. Background Under the Medicare program, eligible beneficiaries may receive covered services in a hospice provided certain requirements are met. Section 1861(dd) of the Social Security Act (the Act) establishes distinct criteria for facilities seeking designation as a hospice. Regulations concerning provider agreements are at 42 CFR part 489 and those pertaining to activities relating to the survey and certification of facilities are at 42 CFR part 488. The regulations at 42 CFR part 418 specify the conditions that a hospice must meet to participate in the Medicare program, the scope of covered services, and the conditions for Medicare payment for hospices. Generally, to enter into an agreement, a hospice must first be certified by a state survey agency as complying with the conditions or requirements set forth in part 418. Thereafter, the hospice is subject to regular surveys by a state survey agency to determine whether it VerDate Mar<15>2010 15:22 Nov 04, 2013 Jkt 232001 continues to meet these requirements. However, there is an alternative to surveys by state agencies. Certification by a nationally recognized accreditation program can substitute for ongoing state review. Section 1865(a)(1) of the Act provides that, if a provider entity demonstrates through accreditation by an approved national accrediting organization that all applicable Medicare conditions are met or exceeded, CMS will deem those provider entities as having met the requirements. Accreditation by an accrediting organization is voluntary and is not required for Medicare participation. If an accrediting organization is recognized by the Secretary of the Department of Health and Human Services as having standards for accreditation that meet or exceed Medicare requirements, any provider entity accredited by the national accrediting body’s approved program would be deemed to have met the Medicare conditions. A national accrediting organization applying for approval of its accreditation program under part 488, subpart A, must provide CMS with reasonable assurance that the accrediting organization requires the accredited provider entities to meet requirements that are at least as stringent as the Medicare conditions. Our regulations concerning the approval of accrediting organizations are set forth at § 488.4 and § 488.8(d)(3). The regulations at § 488.8(d)(3) require accrediting organizations to reapply for continued approval of its accreditation program every 6 years or sooner as determined by CMS. The ACHC’s current term of approval for their hospice accreditation program expires November 27, 2013. II. Application Approval Process Section 1865(a)(3)(A) of the Act provides a statutory timetable to ensure that our review of applications for CMSapproval of an accreditation program is conducted in a timely manner. The Act provides us 210 days after the date of receipt of a complete application, with any documentation necessary to make the determination, to complete our survey activities and application process. Within 60 days after receiving a complete application, we must publish a notice in the Federal Register that identifies the national accrediting body making the request, describes the request, and provides no less than a 30day public comment period. At the end of the 210-day period, we must publish a notice in the Federal Register approving or denying the application. PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 III. Provisions of the Proposed Notice On May 3, 2013, we published a proposed notice in the Federal Register (78 FR 26036) announcing Accreditation Commission for Health Care’s request for approval of its hospice accreditation program. In the proposed notice, we detailed our evaluation criteria. Under section 1865(a)(2) of the Act and in our regulations at § 488.4 and § 488.8, we conducted a review of ACHC’s application in accordance with the criteria specified by our regulations, which include, but are not limited to the following: • An onsite administrative review of ACHC’s: (1) Corporate policies; (2) financial and human resources available to accomplish the proposed surveys; (3) procedures for training, monitoring, and evaluation of its surveyors; (4) ability to investigate and respond appropriately to complaints against accredited facilities; and (5) survey review and decisionmaking process for accreditation. • The comparison of ACHC’s accreditation requirements to our current Medicare hospice conditions of participation. • A documentation review of ACHC’s survey process to determine the following: ++ The composition of the survey team, surveyor qualifications, and ACHC’s ability to provide continuing survey or training. ++ Comparability of ACHC’s processes to those of state survey agencies, including survey frequency, and the ability to investigate and respond appropriately to complaints against accredited facilities. ++ ACHC’s procedures for monitoring hospices out of compliance with ACHC’s program requirements. The monitoring procedures are used only when ACHC identifies noncompliance. If noncompliance is identified through validation reviews, the State survey agency monitors corrections as specified at § 488.7(d). ++ ACHC’s ability to report deficiencies to the surveyed facilities and respond to the facility’s plan of correction in a timely manner. ++ ACHC’s ability to provide CMS with electronic data and reports necessary for effective validation and assessment of the organization’s survey process. ++ The adequacy of staff and other resources. ++ ACHC’s ability to provide adequate funding for performing required surveys. ++ ACHC’s policies with respect to whether surveys are announced or unannounced. E:\FR\FM\05NON1.SGM 05NON1

Agencies

[Federal Register Volume 78, Number 214 (Tuesday, November 5, 2013)]
[Notices]
[Pages 66363-66364]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-26469]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60-Day-14-0210]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-7570 or 
send comments to CDC, LeRoy Richardson, 1600 Clifton Road, MS D-74, 
Atlanta, GA 30333 or send an email to omb@cdc.gov.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    List of Ingredients Added to Tobacco in the Manufacture of 
Cigarette Products (OMB No. 0920-0210, exp. 2/28/2014)--Extension--
Office on Smoking and Health, National Center for Chronic Disease 
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control 
and Prevention (CDC).

Background and Brief Description

    Cigarette smoking is the leading preventable cause of premature 
death and disability in the United States. Each year, more than 443,000 
premature deaths occur as the result of diseases related to cigarette 
smoking. The Centers for Disease Control and Prevention (CDC), Office 
on Smoking and Health (OSH) has the primary responsibility for the 
Department of Health and Human Services (HHS) smoking and health 
program. HHS's overall goal is to reduce death and disability resulting 
from cigarette smoking and other forms of tobacco use through programs 
of information, education and research.
    The Comprehensive Smoking Education Act of 1984 (CSEA, 15 U.S.C. 
1336 or Pub. L. 98-474) requires each person who manufactures, 
packages, or imports cigarettes to provide the Secretary of HHS with a 
list of ingredients added to tobacco in the manufacture of cigarettes. 
The legislation also authorizes HHS to undertake research, and to 
report to the Congress (as deemed appropriate) discussing the health 
effects of these ingredients.
    HHS has delegated responsibility for implementing the CSEA's 
ingredient reporting requirements to CDC's OSH. OSH has collected 
ingredient reports on cigarette products since 1986. Respondents are 
commercial cigarette manufacturers, packagers, or importers, or their 
designated representatives. Respondents are not required to submit 
specific forms; however, they are required to submit a list of all 
ingredients used in their products. CDC requires the ingredient report 
to be submitted by chemical name and Chemical Abstract Service (CAS) 
Registration Number, consistent with accepted reporting practices for 
other companies currently required to report ingredients added to other 
consumer products. Typically, respondents submit a summary report to 
CDC with the ingredient information for multiple products, or a 
statement that there are no changes to their previously submitted 
ingredient report. The estimated burden per response is 6.5 hours. The 
total estimated annualized burden hours are 501.
    Ingredient reports for new products are due at the time of first 
importation. Thereafter, ingredient reports are due annually on March 
31. Information is submitted to OSH by mailing a written report on the 
respondent's letterhead, which may be accompanied by a compact disk 
(CD), three-inch floppy disk, or thumb drive. Annual ingredient reports 
should be mailed to: Office on Smoking and Health, Attention: FCLAA 
Program Manager, National Center for Chronic Disease Prevention and 
Health Promotion, Centers for Disease Control and Prevention, 4770 
Buford Highway, NE., MS F-79 Atlanta, GA 30341-3717. Electronic mail 
submissions are not accepted. Upon receipt and verification of the 
annual ingredient report, OSH issues a Certificate of Compliance to the 
respondent.
    There are no costs to respondents other than their time. Office of 
Management and Budget (OMB) approval is requested for three years.
    Estimated Annualized Burden Hours

----------------------------------------------------------------------------------------------------------------
                                                                  Number of      Average burden
             Type of respondents                 Number of      responses per     per response     Total burden
                                                respondents       respondent       (in hours)       (in hours)
----------------------------------------------------------------------------------------------------------------
Cigarette Manufacturers, Packagers, and                   77                1              6.5              501
 Importers..................................
----------------------------------------------------------------------------------------------------------------



[[Page 66364]]

Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2013-26469 Filed 11-4-13; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.